Skip to content
Medical Health Aged Care, Women

Early detection for 40,000 women per year: Breast and Cancer Centre celebrates 30th birthday

Eastern Health 2 mins read

•    This year the Eastern Health Maroondah Breast and Cancer Centre service celebrates its 30th birthday.

•    The program is focused on the early detection of breast cancer in clients without symptoms.

•    The Centre screens 40,000 consumers per year.

•    Over the past 30 years, the service has offered approximately 930,000 appointments and the team are eagerly anticipating their millionth appointment in 2025.

---------------------------------------------------------------------------------------------
PHOTOS: Available for download here.
---------------------------------------------------------------------------------------------

This year the BreastScreen service celebrates its 30th birthday. Associate Program Director Maroondah BreastScreen, Michelle Giles shares how much the service has changed since its inception three decades ago.

“Maroondah commenced operations at 24 Grey Street in a small weather board house in January 1994. The first consumer was screened by our then Designated Radiographer Liz Sundram. The client list was delivered by a courier on a floppy disc and left under the doormat.

“The service started with film screening before progressing to computer radiography and then full view digital mammography.

“Today, we operate out of a state-of-the-art Breast and Cancer Centre at Eastern Health Maroondah with additional fixed sites.

“Our mobile van, which started in October 1994, continues to serve regional areas,” she said.

The program is focused on the early detection of breast cancer in clients without symptoms and the Centre screens 40,000 consumers per year. 

Its 30-year journey has been marked by significant technological advancements. One area of focus has been the introduction of new 3D imaging technology.

“Maroondah BreastScreen was the first BreastScreen service in Australia to offer tomosynthesis (3D imaging) in the BreastScreen Assessment setting. This project led to the rollout of tomosynthesis in the BreastScreen assessment setting across Victoria. 

“Another area of focus has been providing consumers with information about modifiable breast cancer risk factors like alcohol consumption. This project is a collaboration between Eastern Health Turning Point, Maroondah BreastScreen, and BreastScreen Victoria,” Ms Giles said.

Over the past 30 years, the service has offered approximately 930,000 appointments and the team are eagerly anticipating their millionth appointment in 2025.

“Early detection provides clients with a better prognosis, and we strongly encourage women aged between 50 and 74 to screen every two years so any change in their breast tissue can be detected as early as possible.”


Contact details:

Marianna Alepidis

Media Officer

marianthe.alepidis@easternhealth.org.au

0437 875 825

More from this category

  • Medical Health Aged Care
  • 15/01/2025
  • 20:54
Glaxo SmithKline

Local scientific discovery Omjarra (momelotinib) TGA approved for Australians with rare bone marrow cancer

MELBOURNE PHOTO-FILMING OPPORTUNITY: THURSDAY 16TH JANUARY 2025 DATE: Thursday 16th January 2025 TIME: 10.30 – 11.30am LOCATION: 3 Torresdale Road, Toorak, Melbourne INTERVIEWEES: Prof…

  • Contains:
  • Medical Health Aged Care
  • 15/01/2025
  • 10:33
Monash University

The Lancet Diabetes & Endocrinology: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.

A global Commission, published in The Lancet Diabetes & Endocrinology and endorsed by 75 medical organisations around the world [1], presents a novel, nuanced approach to diagnose obesity, based on other measures of excess body fat in addition to body mass index (BMI), and objective signs and symptoms of ill health at the individual level. The proposal is designed to address limitations in the traditional definition and diagnosis of obesity that hinder clinical practice and healthcare policies, resulting in individuals with obesity not receiving the care they need. By providing a medically coherent framework for disease diagnosis, the Commission also…

  • Medical Health Aged Care
  • 14/01/2025
  • 17:10
Galderma

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™ effectively improved the facial aesthetic appearance of…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.